Results 51 to 60 of about 4,608 (197)

Osteology of the Feeding Apparatus of Chilean Flamingo Phoenicopterus chilensis (Aves: Phoenicopteridae)

Journal of Morphology, Volume 287, Issue 3, March 2026.
1. The skull features a broad, dorsoventrally flattened frontal region articulating with an elongated upper jaw that is complemented by the mandible's downward bend along its proximal half. 2. The low mechanical advantage in the mandible is attributed to the reduced and shallow insertion areas of the adductor muscles, which are positioned close to the ...
Oscar Aldana Ardila, Caio J. Carlos
wiley   +1 more source

Risk of bowel ischemia in patients with mesenteric neuroendocrine tumors after treatment with 177Lu-DOTATATE

Endocrine Oncology
Background: Lutetium-177 (177Lu)-DOTATATE is an effective treatment for metastatic gastroenteropancreatic (GEP) NETs. However, radiation can cause transient inflammation/swelling of tumors, which can result in toxicity.
Eleonora Pelle, Taymeyah Al-Toubah, Ghassan El-Haddad, Brian Morse, Bhavana Konda, Vineeth Sukrithan, Jonathan Strosberg   +6 more
doaj   +1 more source

Recommendations for bone‐directed therapy in patients with neuroendocrine tumour skeletal metastases at the New Zealand National Neuroendocrine Tumour Multidisciplinary Meeting

Internal Medicine Journal, Volume 56, Issue 3, Page 465-468, March 2026.
Abstract The role of anti‐resorptive agents in patients with bone metastases from neuroendocrine neoplasms is unclear. Our aim was to review bone‐specific treatment recommendations by the New Zealand National Neuroendocrine Tumour Multidisciplinary Meeting (MDM).
Gayle Radley, Marianne S Elston, Ben Lawrence, Veronica Boyle   +3 more
wiley   +1 more source

PRRT™: Project Rework Reduction Tool

, 2007
PRRTTM was designed to engage all project participants and stakeholders. Implemented as early as possible in a project’s timeline, it promises to consistently improve the likelihood of project success through the elimination of rework at all phases in all of projects development.
openaire   +5 more sources

Value of Peptide Receptor Radionuclide Therapy as Neoadjuvant Treatment in the Management of Primary Inoperable Neuroendocrine Tumors

Frontiers in Oncology, 2021
IntroductionNeuroendocrine neoplasms including neuroendocrine tumors (NETs) are often diagnosed as primary disseminated or inoperable. In those cases, systemic extensive therapy is necessary, but radical treatment is unlikely.
Marta Opalińska, Anna Sowa-Staszczak, Anna Grochowska, Helena Olearska, Alicja Hubalewska-Dydejczyk   +4 more
doaj   +1 more source

Follow‐up is not justified in patients with typical lung carcinoids without lymph node involvement treated with curative intent: A Danish Multi‐ENETS Center of Excellence Study

Journal of Neuroendocrinology, Volume 38, Issue 3, March 2026.
Abstract Typical carcinoids (TC) are neuroendocrine malignancies of the lung with low risk of recurrence and a favorable prognosis. It is unclear whether lymph node status and tumor size affect the recurrence risk. Following radical surgery, current guidelines recommend comprehensive follow‐up including regular computed tomography (CT) imaging.
Tobias Stemann Lau, Patrick Soldath, Karina Stubkjær Rewitz, Peter Jepsen, Ulrich Knigge, Seppo W. Langer, René Horsleben Petersen, Mikkel Andreassen, Gitte Dam   +8 more
wiley   +1 more source

Success of 177Lu-DOTATATE therapy in a metastatic pituitary neuroendocrine tumor

Endocrine Oncology
Metastatic pituitary neuroendocrine tumors (PitNETs) are rare and often aggressive. Patients should be evaluated for metastatic disease when their biochemical presentation is discordant with pituitary tumor burden or when they present with non-pituitary,
Katherine I Wolf, Zhonglin Lu, Elizabeth A Hesseltine, Ka-Kit Wong, Francis P Worden, Tobias Else   +5 more
doaj   +1 more source

Indications of Peptide Receptor Radionuclide Therapy (PRRT) in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors: An Updated Review [PDF]

, 2021
Baptiste Camus, Anne‐Ségolène Cottereau, Lola‐Jade Palmieri, Solène Dermine, Florence Tenenbaum, Catherine Brézault, Romain Coriat   +6 more
openalex   +1 more source

¹⁷⁷Lu-DOTATATE PRRT in Recurrent Skull-Base Phosphaturic Mesenchymal Tumor Causing Osteomalacia: A Potential Application of PRRT Beyond Neuroendocrine Tumors [PDF]

Journal of Nuclear Medicine Technology, 2016
The potential of peptide receptor radionuclide therapy (PRRT) is described in a case of recurrent inoperable phosphaturic mesenchymal tumor causing osteomalacia in the left basiocciput, for which the patient had undergone surgery twice previously. After one cycle of PRRT, there was good symptomatic improvement, with a modest reduction in uptake on both
Sandip, Basu, Preeti, Fargose
openaire   +2 more sources

Clinical Implications of Ki‐67 Index, Grade and Hormonal Changes in Pancreatic Neuroendocrine Tumors: Insights Into Tumor Heterogeneity Based on Primary and Secondary Lesions

Journal of Hepato-Biliary-Pancreatic Sciences, Volume 33, Issue 2, Page 141-150, February 2026.
In this retrospective study of metastatic and recurrent pancreatic neuroendocrine tumors, Murakami and colleagues demonstrated frequent discordance in Ki‐67 index and World Health Organization grade between primary and secondary lesions. Increased proliferation did not compromise survival, likely reflecting treatment adaptation. Rare hormonal phenotype
Masatoshi Murakami, Nao Fujimori, Kazuhide Matsumoto, Keijiro Ueda, Kohei Nakata, Masafumi Nakamura, Takeo Yamamoto, Yoshinao Oda, Tetsuhide Ito, Yoshihiro Ogawa   +9 more
wiley   +1 more source